First Asia-Pacific Experience of Trans-bronchial Core Biopsy with a Franseen Needle

Overview

Journal J Thorac Dis

Publisher AME Publishing Company

Specialty Pulmonary Medicine

Date 2023 Jul 10

PMID 37426168

Authors

Michael V Brown

Katherine Lavrencic

Arash Badiei

Hubertus Jersmann

Andrew Fon

Sean Chang

Phan Nguyen

Affiliations

Soon will be listed here.

Abstract

Background: Endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) is the standard for evaluating mediastinal and hilar lesions. EBUS-TBNA is limited by small volume of material obtained for immunohistochemistry (IHC) and ancillary studies important for oncological therapies. The Franseen Acquire needle is designed for EBUS-transbronchial needle core biopsy (TBNB) allowing larger core sizes with evidence in gastroenterology literature but little in pulmonology. This study reports the first Asia-Pacific experience of EBUS-TBNB and adequacy of samples for diagnosis and ancillary studies.

Methods: A retrospective cohort study of EBUS-TBNB at the Royal Adelaide Hospital was conducted between December 2019 and May 2021. Diagnostic rate, adequacy for ancillary studies and complications were evaluated. Samples were flushed into formalin for histological processing with no rapid on-site cytological evaluation (ROSE). For suspected lymphoma, samples were flushed into HANKS for flow cytometry. Cases performed with the Olympus Vizishot during the same 18-month were similarly analysed.

Results: One hundred and eighty-nine patients were sampled with the Acquire needle. Diagnostic rate was 174/189 (92.1%). Where reported [146/189 (77.2%)], average core aggregate sample size was 13.4 mm × 10.7 mm × 1.7 mm. For non-small cell lung cancer (NSCLC) cases, 45/49 (91.8%) had adequate tissue for programmed cell death-ligand 1 (PD-L1). 32/35 (91.4%) adenocarcinoma cases had sufficient tissue for ancillary studies. There was one false negative malignant lymph node at the first Acquire procedure. There were no major complications. One hundred and one patients were sampled with the Vizishot needle. Diagnostic rate was 86/101 (85.1%) with only 25/101 (24.8%) having reported tissue cores (P<0.0001 of Vizishot) with the remaining samples processed via cell block.

Conclusions: Acquire EBUS-TBNB diagnostic rate is comparable to historical data with >90% of cases having sufficient core material for ancillary studies. There appears to be a role for the Acquire alongside the standard of care for the work up of lymphadenopathy and particularly for lung cancer.

Citing Articles

Franseen needle in endobronchial ultrasound-guided transbronchial needle aspiration: a phase II prospective study.

Shikano K, Ikari J, Nakajima T, Ota M, Shiko Y, Naito A Jpn J Clin Oncol. 2024; 54(9):1037-1044.

PMID: 38864253 PMC: 11375049. DOI: 10.1093/jjco/hyae077.

References

Hopkins E, Moffat D, Parkinson I, Robinson P, Jersmann H, Dougherty B . Cell block samples from endobronchial ultrasound transbronchial needle aspiration provide sufficient material for ancillary testing in lung cancer-a quaternary referral centre experience. J Thorac Dis. 2016; 8(9):2544-2550. PMC: 5059266. DOI: 10.21037/jtd.2016.08.74. View

Adler D, Muthusamy V, Ehrlich D, Parasher G, Thosani N, Chen A . A multicenter evaluation of a new EUS core biopsy needle: Experience in 200 patients. Endosc Ultrasound. 2018; 8(2):99-104. PMC: 6482605. DOI: 10.4103/eus.eus_53_17. View

Nakajima T, Yasufuku K, Saegusa F, Fujiwara T, Sakairi Y, Hiroshima K . Rapid on-site cytologic evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for nodal staging in patients with lung cancer. Ann Thorac Surg. 2012; 95(5):1695-9. DOI: 10.1016/j.athoracsur.2012.09.074. View

Navani N, Lawrence D, Kolvekar S, Hayward M, McAsey D, Kocjan G . Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trial. Am J Respir Crit Care Med. 2012; 186(3):255-60. PMC: 3423452. DOI: 10.1164/rccm.201203-0393OC. View

Tyan C, Machuca T, Czarnecka K, Ko H, da Cunha Santos G, Boerner S . Performance of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Diagnosis of Isolated Mediastinal and Hilar Lymphadenopathy. Respiration. 2017; 94(5):457-464. DOI: 10.1159/000479745. View

Rusch V, Asamura H, Watanabe H, Giroux D, Rami-Porta R, Goldstraw P . The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009; 4(5):568-77. DOI: 10.1097/JTO.0b013e3181a0d82e. View

Bang J, Hebert-Magee S, Navaneethan U, Hasan M, Hawes R, Varadarajulu S . Randomized trial comparing the Franseen and Fork-tip needles for EUS-guided fine-needle biopsy sampling of solid pancreatic mass lesions. Gastrointest Endosc. 2018; 87(6):1432-1438. DOI: 10.1016/j.gie.2017.11.036. View

Gu P, Zhao Y, Jiang L, Zhang W, Xin Y, Han B . Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis. Eur J Cancer. 2009; 45(8):1389-96. DOI: 10.1016/j.ejca.2008.11.043. View

Labarca G, Sierra-Ruiz M, Kheir F, Folch E, Majid A, Mehta H . Diagnostic Accuracy of Endobronchial Ultrasound Transbronchial Needle Aspiration in Lymphoma. A Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2019; 16(11):1432-1439. DOI: 10.1513/AnnalsATS.201902-175OC. View

10.

Balwan A, Bixby B, Grotepas C, Witt B, Iravani A, Ansari S . Core needle biopsy with endobronchial ultrasonography: single center experience with 100 cases. J Am Soc Cytopathol. 2020; 9(4):249-253. DOI: 10.1016/j.jasc.2020.04.009. View

11.

Martin-Deleon R, Teixido C, Lucena C, Martinez D, Fontana A, Reyes R . EBUS-TBNA Cytological Samples for Comprehensive Molecular Testing in Non-Small Cell Lung Cancer. Cancers (Basel). 2021; 13(9). PMC: 8123471. DOI: 10.3390/cancers13092084. View

12.

Guo H, Liu S, Guo J, Li B, Li W, Lu Z . Rapid on-site evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of hilar and mediastinal lymphadenopathy in patients with lung cancer. Cancer Lett. 2015; 371(2):182-6. DOI: 10.1016/j.canlet.2015.11.038. View

13.

Righi L, Franzi F, Montarolo F, Gatti G, Bongiovanni M, Sessa F . Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)-from morphology to molecular testing. J Thorac Dis. 2017; 9(Suppl 5):S395-S404. PMC: 5459867. DOI: 10.21037/jtd.2017.03.158. View

14.

Osmani L, Askin F, Gabrielson E, Li Q . Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy. Semin Cancer Biol. 2017; 52(Pt 1):103-109. PMC: 5970946. DOI: 10.1016/j.semcancer.2017.11.019. View

15.

Diehl D, Johal A, Khara H, Stavropoulos S, Al-Haddad M, Ramesh J . Endoscopic ultrasound-guided liver biopsy: a multicenter experience. Endosc Int Open. 2015; 3(3):E210-5. PMC: 4486032. DOI: 10.1055/s-0034-1391412. View

16.

Velu P, Reid P, Wallace W, Skwarski K . Isolated mediastinal lymphadenopathy - performance of EBUS-TBNA in clinical practice. J R Coll Physicians Edinb. 2017; 47(1):52-56. DOI: 10.4997/JRCPE.2017.111. View

17.

Turner S, Buonocore D, Desmeules P, Rekhtman N, Dogan S, Lin O . Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients. Lung Cancer. 2018; 119:85-90. PMC: 5905717. DOI: 10.1016/j.lungcan.2018.03.003. View

18.

Dhooria S, Sehgal I, Prasad K, Muthu V, Gupta N, Bal A . Diagnostic yield and safety of the ProCore versus the standard EBUS-TBNA needle in subjects with suspected sarcoidosis. Expert Rev Med Devices. 2021; 18(2):211-216. DOI: 10.1080/17434440.2021.1876560. View

19.

Labarca G, Folch E, Jantz M, Mehta H, Majid A, Fernandez-Bussy S . Adequacy of Samples Obtained by Endobronchial Ultrasound with Transbronchial Needle Aspiration for Molecular Analysis in Patients with Non-Small Cell Lung Cancer. Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2018; 15(10):1205-1216. DOI: 10.1513/AnnalsATS.201801-045OC. View

20.

da Cunha Santos G, Ko H, Saieg M, Geddie W . "The petals and thorns" of ROSE (rapid on-site evaluation). Cancer Cytopathol. 2012; 121(1):4-8. DOI: 10.1002/cncy.21215. View